BlackRock Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$135K Buy
44,406
+2,667
+6% +$8.11K ﹤0.01% 2755
2016
Q3
$193K Buy
41,739
+1,143
+3% +$5.29K ﹤0.01% 2626
2016
Q2
$235K Sell
40,596
-26,360
-39% -$153K ﹤0.01% 2513
2016
Q1
$405K Buy
66,956
+9,095
+16% +$55K ﹤0.01% 2307
2015
Q4
$529K Sell
57,861
-509
-0.9% -$4.65K ﹤0.01% 2166
2015
Q3
$329K Buy
58,370
+29,865
+105% +$168K ﹤0.01% 2354
2015
Q2
$316K Buy
28,505
+3,175
+13% +$35.2K ﹤0.01% 2422
2015
Q1
$397K Buy
25,330
+16,532
+188% +$259K ﹤0.01% 2271
2014
Q4
$134K Buy
8,798
+889
+11% +$13.5K ﹤0.01% 2604
2014
Q3
$85K Sell
7,909
-254
-3% -$2.73K ﹤0.01% 2592
2014
Q2
$124K Sell
8,163
-568
-7% -$8.63K ﹤0.01% 2532
2014
Q1
$158K Buy
8,731
+5,504
+171% +$99.6K ﹤0.01% 2478
2013
Q4
$45K Buy
+3,227
New +$45K ﹤0.01% 2543